Prostacyclin production by whole blood from children: impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure

Thromb Res. 1983 Apr 1;30(1):13-8. doi: 10.1016/0049-3848(83)90392-4.

Abstract

The capacity of leukocytes to produce prostacyclin (PGI2) from endogenous and from platelet-derived endoperoxides was tested in whole blood. During the acute phase of the hemolytic uremic syndrome (H.U.S.), the PGI2-production was lower than the controls, whereas the blood from children with chronic renal failure produced higher amounts. Production of PGI2 by blood from children 3/12 to 6 years after the acute phase of H.U.S. was normal, as was the case with blood from their parents. Furthermore, in two H.U.S.-patients studied serially, the decreased PGI2-production capacity normalized 2 1/2 months after the acute phase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / biosynthesis
  • Adolescent
  • Child
  • Child, Preschool
  • Epoprostenol / biosynthesis*
  • Hemolytic-Uremic Syndrome / blood*
  • Humans
  • Infant
  • Kidney Failure, Chronic / blood*
  • Leukocytes / metabolism*
  • Prostaglandins / biosynthesis*
  • Thromboxane B2 / biosynthesis

Substances

  • Prostaglandins
  • Thromboxane B2
  • 6-Ketoprostaglandin F1 alpha
  • Epoprostenol